COVID-19 and Atrial Fibrillation in Older Patients: Does Oral Anticoagulant Therapy Provide a Survival Benefit?—An Insight from the GeroCovid Registry
Stefano Fumagalli(University of Florence), Alessandra Coin(University of Padua), Enrico Mossello(University of Florence), Raffaele Antonelli Incalzi(Campus Bio Medico University Hospital), Giuseppe Bellelli(Azienda Ospedaliera San Gerardo), Caterina Trevisan(University of Padua), Gianluca Zia, Fabio Monzani(University of Pisa), Alba Malara(Humanitas University), Giulia Pelagalli(University of Florence), Pietro Gareri, Stefano Volpato(University of Ferrara), Susanna Del Signore
Cited by 33
Related Papers
Short Physical Performance Battery and all-cause mortality: systematic review and meta-analysis
|BMC Medicine|2016|904
Handgrip Strength and Cause‐Specific and Total Mortality in Older Disabled Women: Exploring the Mechanism
|Journal of the American Geriatrics Society|2003|664
Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels
|Journal of the American Geriatrics Society|2002|619
Predictive Value of the Short Physical Performance Battery Following Hospitalization in Older Patients
|The Journals of Gerontology Series A|2010|465
Cardiovascular Disease, Interleukin-6, and Risk of Mortality in Older Women
|Circulation|2001|433